Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That would be a good move. I like that!
Are you a securities lawyer offering a professional opinion or just a guy making something up because it sounds plausible to him or fits a comforting narrative? I think I know the answer but I’m asking anyway.
“On another issue, if he were to leave what would be the new primary fudster talking point?”
Well, I don’t consider myself a FUDster since all I’m doing is expressing my opinions of our CEO’s performance and that of the board of directors in coddling him. I’ve NEVER said or even implied that anyone should sell and I don’t care what anybody does with their money except to behave in a financially responsible manner. However, to answer your accusatory question, I personally would have nothing negative to say. If a competent CEO were hired and that person had a track record of success in drug development, business development, regulatory affairs, and commercialization leading to enhanced shareholder value, I would 1) Add to my position, and 2) Sit back and give it additional time.
I honestly don’t see why the ongoing litigation would be a reason to delay the ASM. The litigation could go on for quite a while. Also, most public companies are in litigation for one thing or another all the time. It doesn’t prevent them from holding an annual meeting.
Maybe I’m guilty of wishful thinking but I still can’t think of a better explanation for the delay. However, since I’m not a securities lawyer and I’m not familiar with the rules for public companies incorporated in Nevada, I admit I could be missing important information.
If there is a securities lawyer reading this board, it sure would be interesting to get your a professional opinion.
I’m being very honest about my belief that the proxy and annual meeting are delayed while the board and Missling negotiate the termination of his contract. I honestly cannot think of any other realistic reason for a delay like this. I don’t believe for a second that Missling is waiting for good news so that he can have something positive to discuss. I’ve never seen that happen.
Maybe I'm dreaming but there’s simply no other explanation I can think of that would make sense.
My hope is that the proxy is late because the board is negotiating the termination of Missling’s contract and looking to bring on a new CEO before holding the annual meeting.
That’s the only reason I can think of for the delay. Surely it’s not because Missling is on vacation or waiting for some positive news.
Zero credibility. Just like Missling.
I’ll add that to my list of excuses for letting Missling off the hook.
Congratulations. There’s no limit on how creative these excuses get.
They can’t do their job if Missling doesn't do his job.
At Dec. 31, Anavex had $143 million in cash and 82 million shares outstanding. That’s $1.80 a share in cash at year end. The stock closed today at $3.39. That means the market is valuing Anavex’s pipeline, technology, and patents at $1.59 a share.
Not exactly a ringing endorsement for what the WGTers believe will be the world’s first trillion dollar drug.
You’re putting words in my mouth. I never said the trials were fabricated using crash test dummies or some other such nonsense.
Let’s revisit.
You claimed they are resource constrained and therefore focusing on Europe first. I countered that with 4+ years of cash, 40+ employees (plus consultants), and one small trial in the clinic that they surely have the resources to file in both Australia and Europe at the same time. I further suggested that filing in Australia might run in the low millions but surely would not break the piggy bank, and that the sooner they filed in Australia the sooner they could potentially start generating millions in revenues.
I’m not sure Blarcamesine would help you with maintaining focus on the issue at hand but I suspect this does not require medical intervention.
Your arguments and excuses are weak.
“They do not have unlimited resources.”
Four years of cash on hand and 40+ employees (plus consultants) and they don’t have the resources to file in Australia and Europe at the same time? It’s not like they’re running 10 clinical programs. That is just another excuse that doesn’t hold water. How much could it possibly cost to file in Australia? Maybe low millions? Certainly not tens of millions. And the sooner they filed in Australia the sooner they’d be generating millions in revenues in Australia.
On this MB It’s just one excuse after another. I’ve never seen anything like it.
I’ll restate what I’ve said previously. If a big pharma thought Anavex had the best approach or even a viable approach to CNS diseases, they’d have acquired the company already even if they had to pay a big premium. At the current market cap, this is lunch money for pharma.
I believe shareholders would be thrilled to get $10-$12 right now if it was offered.
Keep dreaming. Missling is a one-man band. He does not let anybody “do what they do”. This has been obvious for years. This is a CEO who writes his own press releases, writes his own presentations and conference call scripts, and manages the website. Also, he never lets anyone else (like his CMO) do any presentations or speak on the conference calls. It’s his show and his show only. Even as you defend and misread the guy, your investment in AVXL is tanking even as the markets reach all-time highs. You’d have been better off buying an index fund that tracks the S&P 500 than trusting Missling with your hard-earned money.
Being defensive instead of accepting the reality of the situation has cost you dearly. I guess you can afford to lose your investment’s value.
That’s like saying the plane will fly itself and the pilot doesn’t matter.
Your logic is a recipe for financial disaster. I hope you’re very wealthy and haven’t made AVXL the linchpin of your retirement.
Some people have finally woken up to the truth about Missling. Maybe one day you’ll wake up, too. In the meantime, enjoy watching your net worth disappear.
Paranoid delusional conspiratorial nonsense with no hard evidence to back it up. Are all these corrupt cabalists that live in your imagination stopping Missling from releasing the full PDD and AD data sets? Are they responsible for his fumbles, stumbles, goal-post moving, cherry picking of data, and terrible communications?
Missling alone is responsible for the collapse in shareholder value, yet you just can’t bring yourself to hold him even partly responsible.
I guess it’s more important to you to protect Missling (and your own reputation) than to make money.
SMH.
Don’t be disrespectful to dogs. Dogs deserve better.
Missling is delaying, delaying, delaying so that he can continue to get paid for as long as possible because he knows this is the last CEO job he’ll ever get.
So many conspiracy theories, so little time. Of course, there isn’t a shred of hard evidence that AVXL is under attack by WS but that doesn’t stop some people from believing it anyway. Better to believe in conspiracy theories than to accept the fact that our CEO is an incompetent boob who shouldn’t be running an ice cream shop let alone a biotech company and that blind faith in him is totally misplaced.
If you (or anybody reading this) really believe Wall Street is so corrupt, sell all of your stocks and mutual funds and park your money elsewhere.
Such a tired old excuse. Just admit you were wrong. It’ll be liberating for you.
The answer is obvious. It was longtermbeliever. Who else has the capacity to buy in such quantity?
“Credibility matters.”
And how.
Credibility and reputation, two things totally lacking at Anavex. Missling could be a genius and it wouldn’t matter. He’s proven himself to be a total liability. Investors don’t take him seriously. Neither does big pharma. The stock price tells us everything we need to know.
Missling is not indispensable. He can and should be replaced. It’s time!
Still no date for annual meeting? Hmmm… that’s weird. Maybe Missling and the BOD are negotiating the termination of his contract and the BOD wants to announce a new CEO before holding the annual meeting.
One can only hope…
Remember when our favorite pumper said Anavex is one of the world’s greatest companies and Missling is one of the world’s greatest CEOs?
How’s that working out? Hahahaha!
This is dead money for the foreseeable future. It appears nobody is excited except short sellers and delusional anti-vaxxers.
Georgejjl has a very loose definition of ABSOLUTELY GREAT NEWS. Basically, anything Anavex announces, including a new patent filing, Georgejjl considers to be ABSOLUTELY GREAT NEWS. Therefore, he can never be wrong about that. And by saying eventually, he once again can never be wrong. Therefore, no matter what the news and no matter when it happens, Georgejjl will claim he was right.
IMO, it’s twisted and kind of pathetic but there you have it.
I’m waiting for Georgejjl to declare that a 2 cent rise today is the beginning of an uptrend.
Expect the Earth to be struck by a giant meteor eventually soon.
“There just seems to be such a disconnect from reality on this board.”
Hope is an incredibly powerful emotion, especially when you’ve staked so much on the outcome (money and prestige). Nobody knows better than Missling what motivates his shareholders. He’s a master at playing on emotion to keep his shareholders hanging in there.
How about just general nuttiness?
If Anavex’s competitors were “scared to death” as you said, they’d have bought the company by now no matter the price.
Keep dreaming.
Well smart guy, you tell me why you think Anavex needs 70-80 hours of biostatistical work. More broadly, I have no idea what 40+ people could possibly be doing every day. What does Rebowe do all week? What does Tomlinson do all week? Oh, and what does that Barwicki guy do for his monthly retainer? 40 employees times a minimum of 35 hours a week is minimum of 1,400 hours a week (and that does not include the hours spent by any external consultants other than Barwicki). Do you really believe a small biopharma company with one small trial that just barely started needs 40+ people? While it’s true that I’m not there and neither are you, any idiot can see that it doesn’t add up.
Learn to be a little skeptical.
More window dressing. Dr. Jin is there crunching numbers for 35-40 hours a week. Do you mean to tell me there’s so much data to crunch that 40 hours a week isn’t enough? Oh, and that’s on top of the Ariana supercomputers.
It’s also possible Dr. Jin got fed up and left and is being replaced.
Chasing AVXL lower and lower as an investment strategy has surely been a disaster for some folks here. Longtermbeliever, for example has claimed many times to be buying tens of thousands of shares at a time. bas2020 has also stated many times over the past several years that he and his investment group are “putting dry powder to work” to the tune of tens of thousands of shares. Their collective losses must amount to high six figures if not seven figures. I once knew somebody who bought tens of thousands of shares in a company like Anavex and brought his family, colleagues, and friends into the stock with promises of riches. He even took out a second mortgage on his home to buy the stock. When the stock finally collapsed, he lost his job, he lost friends, and he had family members who would not talk to him. He even had to change gyms because he told all his gym buddies to load up.
Remember, about half the market cap is cash.
Theres a huge disconnect between what Missling says in his presentation and what the market perceives. We’ll learn the truth eventually, one way or the other. I’ll continue to hold my remaining shares but I’m not going to bottom fish. If Missling actually gets EMA approval, I’ll gladly pay $20 for a 5X upside. For now, this is still a story stock that the market does now believe in.
AVXL has been a disaster for a great many people who thought they were buying a golden ticket to unimaginable riches. That is a fact. Here’s another fact: It’s Missling’s incompetence or worse that has caused this disaster, not some nefarious cabal or whatever you want to call them.
Paranoid conspiratorial thinking is a cheap excuse that will only lead to more pain.
skitahoe - You haven’t been here very long, so your question is understandable. I would really urge you to take some time to go back over the long history to get better insight into how Missling operates. If you do that, I think you’ll be able to answer your own question. What is absolutely clear to me and many others is that Missling is an autocratic CEO who is a one-man band. Everybody else is window dressing.
Do yourself a favor before you get in too deep and go back over the history. It’ll take some time but it’ll be worth it.
Nothing positive that I can see at least for the foreseeable future, no.
As I have previously said, I sold 90% of my shares in the high 20s during the irrational run up to $31. I bought a new Mercedes with some of the proceeds and invested the remaining proceeds in Nvidia, where I made another killing. My remaining position in Anavex is too small to make any difference in my life. At this point I’m here mainly for the entertainment value.
I think Anavex is in the early stages of circling the drain. Once in the drain there is no going back. The stock price tells us what we need to know. I’ve previously stated why I say that and I see no need to repeat myself. People can blame the market makers, Adam Feuerstein, or whatever. Suffice to say I have been right about Missling/Anavex all along. All the fumbles, stumbles, goal post moving, changing endpoints, fibbing, etc., are finally catching up with him. You can only get away with so much before the party is over.
Maybe the announcement of the date of the annual meeting is being delayed while Missling’s termination is being negotiated.
Expect AVXL to close at or near the intra-day low on selling volume of well over 1 million shares.